Cas no 139086-97-8 (N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97%)

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97%, is a high-purity chemical compound primarily used as an intermediate in pharmaceutical and agrochemical synthesis. Its well-defined structure, featuring chloro and nitro substituents on the pyridine ring, makes it valuable for constructing complex heterocyclic systems. The 97% purity ensures consistency in reactions, minimizing side products and improving yield. This compound is particularly useful in nucleophilic substitution and reduction reactions due to its reactive sites. Suitable for research and industrial applications, it is supplied with detailed analytical data (e.g., HPLC, NMR) to verify quality. Proper handling is advised due to potential sensitivity to moisture and light. Store under inert conditions for optimal stability.
N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97% structure
139086-97-8 structure
Product Name:N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97%
CAS No:139086-97-8
MF:C7H6ClN3O3
MW:215.593840122223
CID:855200
PubChem ID:2783822
Update Time:2025-06-07

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97% Chemical and Physical Properties

Names and Identifiers

    • N-(6-Chloro-3-nitro-2-pyridinyl)acetamide
    • N-(6-Chloro-3-nitropyridin-2-yl)acetamide
    • 2-acetamido-6-chloro-3-nitropyridine
    • SCHEMBL5099519
    • D87260
    • N-(6-chloro-3-nitro-2-pyridyl)acetamide
    • DB-063290
    • N-(6-Chloro-3-nitropyridin-2-yl)acetamide,97%
    • TWNSKFDHCYKQJL-UHFFFAOYSA-N
    • W-205523
    • AKOS015850259
    • CS-0362353
    • 139086-97-8
    • N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97%
    • Inchi: 1S/C7H6ClN3O3/c1-4(12)9-7-5(11(13)14)2-3-6(8)10-7/h2-3H,1H3,(H,9,10,12)
    • InChI Key: TWNSKFDHCYKQJL-UHFFFAOYSA-N
    • SMILES: ClC1=CC=C(C(=N1)NC(C)=O)[N+](=O)[O-]

Computed Properties

  • Exact Mass: 215.01000
  • Monoisotopic Mass: 215.0097688g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 14
  • Rotatable Bond Count: 1
  • Complexity: 243
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.7
  • Topological Polar Surface Area: 87.8?2

Experimental Properties

  • Density: 1.5±0.1 g/cm3
  • Melting Point: Not available
  • Boiling Point: 432.1±45.0 °C at 760 mmHg
  • Flash Point: 215.1±28.7 °C
  • Refractive Index: 1.636
  • PSA: 91.30000
  • LogP: 2.77430
  • Vapor Pressure: 0.0±1.0 mmHg at 25°C

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97% Security Information

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97% Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Ambeed
A323463-1g
N-(6-Chloro-3-nitropyridin-2-yl)acetamide
139086-97-8 95+%
1g
$47.0 2024-04-24
Ambeed
A323463-5g
N-(6-Chloro-3-nitropyridin-2-yl)acetamide
139086-97-8 95+%
5g
$188.0 2024-04-24
1PlusChem
1P009DCZ-100mg
N-(6-CHLORO-3-NITROPYRIDIN-2-YL)ACETAMIDE
139086-97-8 95%
100mg
$89.00 2024-06-21
1PlusChem
1P009DCZ-250mg
N-(6-CHLORO-3-NITROPYRIDIN-2-YL)ACETAMIDE
139086-97-8 95%
250mg
$120.00 2024-06-21
A2B Chem LLC
AE36419-100mg
N-(6-Chloro-3-nitropyridin-2-yl)acetamide
139086-97-8 95%
100mg
$73.00 2024-01-04
A2B Chem LLC
AE36419-250mg
N-(6-Chloro-3-nitropyridin-2-yl)acetamide
139086-97-8 95%
250mg
$101.00 2024-01-04

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97% Production Method

Additional information on N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97%

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97%: A Key Intermediate in Modern Pharmaceutical Research

N-(6-Chloro-3-nitropyridin-2-yl)acetamide, 97% is a high-purity chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, with the CAS number 139086-97-8, serves as a crucial intermediate in the synthesis of various bioactive molecules. Its unique structural properties make it particularly valuable for designing and developing novel therapeutic agents targeting a range of diseases.

The< strong>nitropyridine core of N-(6-Chloro-3-nitropyridin-2-yl)acetamide is a versatile pharmacophore that has been extensively studied for its potential biological activities. The presence of both< strong>chloro and< strong>nitro substituents enhances its reactivity, allowing for further functionalization and the creation of complex molecular structures. This flexibility is particularly advantageous in medicinal chemistry, where the ability to modify and optimize molecular scaffolds is essential for improving drug efficacy and selectivity.

In recent years, there has been a growing interest in developing small molecule inhibitors for kinases and other enzymes involved in cancer progression. N-(6-Chloro-3-nitropyridin-2-yl)acetamide has been explored as a precursor in the synthesis of kinase inhibitors due to its ability to form stable complexes with target proteins. Studies have shown that derivatives of this compound exhibit promising inhibitory activity against various kinases, making them potential candidates for further development into anticancer agents.

The< strong>acetamide moiety in N-(6-Chloro-3-nitropyridin-2-yl)acetamide also contributes to its pharmacological profile by influencing solubility and metabolic stability. This feature is particularly important in drug design, as it can enhance the bioavailability and reduce the toxicity of the final therapeutic agent. Researchers have leveraged these properties to develop prodrugs and other formulations that improve drug delivery and efficacy.

Advances in computational chemistry and high-throughput screening have further accelerated the discovery of new drug candidates derived from N-(6-Chloro-3-nitropyridin-2-yl)acetamide. These techniques allow researchers to predict the binding affinity and specificity of various derivatives, enabling more targeted and efficient drug development processes. The compound's well-documented chemical properties make it an ideal candidate for virtual screening and molecular docking studies, which are integral parts of modern drug discovery pipelines.

The synthesis of N-(6-Chloro-3-nitropyridin-2-yl)acetamide involves multi-step organic reactions that require precise control over reaction conditions. The high purity (97%) ensures that impurities do not interfere with downstream applications, making it a reliable starting material for researchers. The compound's stability under various storage conditions also adds to its practicality in laboratory settings.

In addition to its applications in oncology, N-(6-Chloro-3-nitropyridin-2-yl)acetamide has shown potential in other therapeutic areas, including inflammation and neurodegenerative diseases. Its ability to modulate key biological pathways makes it a valuable tool for exploring new treatment strategies. For instance, studies have indicated that derivatives of this compound may interact with transcription factors and signaling molecules involved in disease pathogenesis.

The growing body of research on N-(6-Chloro-3-nitropyridin-2-yl)acetamide underscores its importance as a building block in pharmaceutical chemistry. As new synthetic methodologies are developed, the accessibility and utility of this compound are expected to expand further. Collaborative efforts between academic institutions and pharmaceutical companies are likely to drive innovation in this field, leading to the discovery of novel therapeutics that address unmet medical needs.

In conclusion, N-(6-Chloro-3-nitropyridin-2-yl)acetamide (CAS no. 139086-97-8) is a multifaceted compound with significant potential in pharmaceutical research. Its unique structural features, combined with its reactivity and stability, make it an invaluable intermediate for developing new drugs. As research continues to uncover its applications across various therapeutic areas, this compound is poised to play a crucial role in advancing modern medicine.

Recommended suppliers
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
SunaTech Inc.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
SunaTech Inc.
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.